| Name | Walgreens #3593 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 2610 W Thunderbird Rd, Phoenix, Arizona 85023 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (602) 993-9900 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"Night owls" -; people who like to stay up late and have trouble dragging themselves out of bed in the morning -; have a higher risk of dying sooner than "larks," people who have a natural preference for going to bed early and rise with the sun, according to a new study from Northwestern Medicine and the University of Surrey in the United Kingdom.
It's called post-operative cognitive decline, a syndrome in which patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness.
Researchers at the University of Waterloo have developed a new technology that could dramatically reduce the number of open-heart surgeries for people with pacemakers.
BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).
With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.
› Verified 5 days ago
| NPI Number | 1356356620 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03593 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2610 W Thunderbird Rd, Phoenix, AZ 85023 |
| Phone Number | 602-993-9900 |
News Archive
"Night owls" -; people who like to stay up late and have trouble dragging themselves out of bed in the morning -; have a higher risk of dying sooner than "larks," people who have a natural preference for going to bed early and rise with the sun, according to a new study from Northwestern Medicine and the University of Surrey in the United Kingdom.
It's called post-operative cognitive decline, a syndrome in which patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness.
Researchers at the University of Waterloo have developed a new technology that could dramatically reduce the number of open-heart surgeries for people with pacemakers.
BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).
With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.
› Verified 5 days ago
News Archive
"Night owls" -; people who like to stay up late and have trouble dragging themselves out of bed in the morning -; have a higher risk of dying sooner than "larks," people who have a natural preference for going to bed early and rise with the sun, according to a new study from Northwestern Medicine and the University of Surrey in the United Kingdom.
It's called post-operative cognitive decline, a syndrome in which patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness.
Researchers at the University of Waterloo have developed a new technology that could dramatically reduce the number of open-heart surgeries for people with pacemakers.
BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).
With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.
› Verified 5 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |